(EMAILWIRE.COM, January 23, 2019 ) The U.S. IVD product & services market is broadly segmented into reagents, instruments, services, and data management system/software. The instruments market is further segmented into fully automated instruments, semi-automated instruments, and other instruments.
Get Free Sample Papers on U.S. In Vitro Diagnostics (IVD) Market Report Updates Now at http://www.reportsnreports.com/contacts/requestsample.aspx?name=512828 .
U.S. In vitro
diagnostics testing is an indispensable tool in the modern medical practice. IVD tests are conducted with the help of various medical devices for diagnosis of a number of diseases. With evolution in biotechnology, there has been a drastic change in type of tests conducted for diagnosing various diseases, thus helping physicians to diagnose and treat diseases promptly and effectively.
U.S. in Vitro Diagnostics Market, By Product & Service
6.1 Introduction
6.2 Reagents
6.3 Instruments
6.3.1 Fully Automated Instruments
6.3.2 Semi-Automated Instruments
6.3.3 Others
6.4 Data Management Software
6.5 Services
U.S. in Vitro Diagnostics Market, By Technology
7.1 Introduction
7.2 Clinical Chemistry
7.3 Immunochemistry/Immunoassays
7.4 Microbiology
7.5 Molecular Diagnostics (MDX)
7.6 Hematology
7.7 Coagulation/Hemostasis
7.8 Other IVD Technologies
U.S. in Vitro Diagnostics Market, By Application
8.1 Introduction
8.2 Infectious Diseases
8.3 Diabetes
8.4 Oncology/Cancer
8.5 Cardiovascular Disorders
8.6 Endocrine Disorders
8.7 Autoimmune Diseases
8.8 Bone & Mineral-Related Diseases
8.9 Pulmonary Diseases
8.10 Other Applications
U.S. in Vitro Diagnostics Market, By End User
9.1 Introduction
9.2 Hospital Laboratories
9.3 Clinical/Independent Laboratories
9.3.1 Large Laboratories/Reference Laboratories
9.3.2 Medium-Sized Laboratories
9.3.3 Small Laboratories
9.4 Other End Users
Most important trend witnessed recently in U.S. IVD market is trend of self-testing as opposed to patients visiting hospitals. This is a key factor driving the growth of point-of-care testing, as patients prefer self-testing to avoid hospital visits. IVD tests have a significant role in the prevention, monitoring, diagnosis, and treatment of diseases. Common IVD tests include blood tests for glucose, tests for detection of electrolytes (calcium, sodium, and potassium), liver enzymes, and drug tests.
Get Upto 50% Discount Now on U.S. In Vitro Diagnostics Market Research Report Now at http://www.whatech.com/market-research/transport/545794-recent-research-vehicle-diagnostics-market-set-to-grow-at-16-79-cagr-and-reach-us-30-22-billion-by-2021 .
The U.S. IVD market is projected to reach USD 25.99 billion by 2020 at a CAGR of 4.7% from 2015 to 2020. The rising incidence of chronic and infectious diseases, rapidly aging population, growing preference for point-of-care testing and personalized medicine, implementation of the Affordable Care Act (ACA), increasing demand for automated instruments, and automation in laboratories are key factors driving the IVD market in the U.S. In this report, the market is segmented by product & service, technology, application, end user, and region. The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater market share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping greater market shares.
More Information on U.S. In Vitro Diagnostics (IVD) Market by Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology), Application (Infectious Diseases, Diabetes, Cancer, Cardiology), End User (Hospitals & Laboratories) & by Region – Forecast to 2020 research report can be requested at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=512828 .
U.S. IVD market is segmented into hospital laboratories, clinical/independent laboratories, and others. In 2017, the hospital laboratories segment accounted for largest share of U.S. IVD market in U.S. The high inpatient flow & ancillary outpatient flow in hospitals, growing prevalence of chronic & infectious diseases, & increasing number of accredited laboratories are key factors driving market growth in this end-user segment.
Snehal
+ 18883915441
sales@reportsandreports.com
Source: EmailWire.Com 
